Figure 1.
Process for determination of phase 1 combination trial design. DLT = dose limiting toxicity; PD = pharmacodynamic; PK = pharmacokinetic.
Process for determination of phase 1 combination trial design. DLT = dose limiting toxicity; PD = pharmacodynamic; PK = pharmacokinetic.